Cargando…

Visfatin/Nampt: An Adipokine with Cardiovascular Impact

Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors termed adipokines. Visfatin was initially identified as a novel adipokine with insulin-mimetic properties in mice. This adipokine was identical to two previously described molecules, namely, pre-B cell colony-enhanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romacho, Tania, Sánchez-Ferrer, Carlos F., Peiró, Concepción
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697395/ https://www.ncbi.nlm.nih.gov/pubmed/23843684 http://dx.doi.org/10.1155/2013/946427

Ejemplares similares

Visfatin/PBEF/Nampt: A New Cardiovascular Target?
por: Peiró, Concepción, et al.
Publicado: (2010)

Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
por: Romacho, Tania, et al.
Publicado: (2020)

Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
por: Romacho, Tania, et al.
Publicado: (2013)

Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis
por: Laiguillon, Marie-Charlotte, et al.
Publicado: (2014)

Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity
por: Vallejo, Susana, et al.
Publicado: (2011)

Secretion of One Adipokine Nampt/Visfatin Suppresses the Inflammatory Stress-Induced NF-κB Activity and Affects Nampt-Dependent Cell Viability in Huh-7 Cells
por: Lin, Yi-Ching, et al.
Publicado: (2015)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

Adipokines Vaspin and Visfatin in Obese Children
por: Salama, Hassan M., et al.
Publicado: (2015)

Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022)

Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in Humans
por: Hallschmid, Manfred, et al.
Publicado: (2009)

Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022)

The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
por: Vallejo, Susana, et al.
Publicado: (2014)

The potential influence of hyperthyroidism on circulating adipokines chemerin, visfatin, and omentin
por: Alshaikh, Eman M., et al.
Publicado: (2019)

Evaluation of Adipokines: Apelin, Visfatin, and Resistin in Children with Atopic Dermatitis
por: Machura, Edyta, et al.
Publicado: (2013)

Nampt/PBEF/visfatin serum levels: a new biomarker for retinal blood vessel occlusions
por: Kaja, Simon, et al.
Publicado: (2015)

Adipokine Serum visfatin level in pregnancy induced hypertension and uncomplicated pregnancy
por: Shaheen, Asmat, et al.
Publicado: (2016)

Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects
por: Saddi-Rosa, Pedro, et al.
Publicado: (2013)

Do monocytes use the novel adipocytokine Visfatin/NAMPT/PBEF1 to flip the HIV coreceptor switch?
por: Bergh, Rafael Van den, et al.
Publicado: (2009)

NAMPT/Visfatin expression by inflammatory monocytes mediates arthritis pathogenesis by promoting IL-17–producing T cells
por: Présumey, Jessy, et al.
Publicado: (2012)

The cardiovascular impact of visfatin - an inflammation predictor biomarker in metabolic syndrome
por: HOGNOGI, LARISA DIANA MOCAN, et al.
Publicado: (2016)

Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway
por: Peiró, Concepción, et al.
Publicado: (2016)

Erratum to: Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway
por: Peiró, Concepción, et al.
Publicado: (2017)

NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritis
por: Yang, Siyoung, et al.
Publicado: (2015)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
por: Chiang, Yi-Fen, et al.
Publicado: (2023)

Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers
por: Srinivasan, Mythily, et al.
Publicado: (2018)

Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT
por: Van den Bergh, Rafael, et al.
Publicado: (2012)

Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes
por: Yammani, Raghunatha R, et al.
Publicado: (2012)

Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models
por: Estienne, Anthony, et al.
Publicado: (2019)

Plasma Adipokines in Patients Resuscitated from Cardiac Arrest: Difference of Visfatin between Survivors and Nonsurvivors
por: Chen, Yuan-Zhuo, et al.
Publicado: (2020)

Nutritional Ingredients Modulate Adipokine Secretion and Inflammation in Human Primary Adipocytes
por: Romacho, Tania, et al.
Publicado: (2015)

Adipokines NUCB2/Nesfatin-1 and Visfatin as Novel Inflammatory Factors in Chronic Obstructive Pulmonary Disease
por: Leivo-Korpela, Sirpa, et al.
Publicado: (2014)

Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans
por: Friebe, D., et al.
Publicado: (2011)

Associations between Tissue Visfatin/Nicotinamide, Phosphoribosyltransferase (Nampt), Retinol Binding Protein-4, and Vaspin Concentrations and Insulin Resistance in Morbidly Obese Subjects
por: Goktas, Zeynep, et al.
Publicado: (2013)

IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
por: Peiró, Concepción, et al.
Publicado: (2017)

Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
por: Kärberg, Kati, et al.
Publicado: (2023)

The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
por: Torretta, Simone, et al.
Publicado: (2020)

The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016)

The Adipokines in Cancer Cachexia
por: Mannelli, Michele, et al.
Publicado: (2020)

Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo
por: Azcutia, Verónica, et al.
Publicado: (2010)

Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter‐endothelial junction disruption: role of HMGB1
por: Chen, Yang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9v115ucm3cv1lqisq04ehogb0m